Novo Nordisk A/S - Share repurchase programme
On 15 August 2008 Novo Nordisk initiated its share repurchase
programme in accordance with the provisions of the European
Commission's regulation no 2273/2003 of 22 December 2003, also
referred to as the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase B shares for an
amount of up to DKK 1.7 billion in the period from 15 August 2008 to
19 December 2008.
Since the announcement as of 20 October 2008, the following
transactions have been made under the programme:
Number of Average Transaction
shares purchase value, DKK
price
Accumulated, 2,588,500 724,205,744
last announcement
20 October 2008 50,000 286.1700 14,308,500
21 October 2008 50,000 281.7050 14,085,250
22 October 2008 50,000 274.5100 13,725,500
23 October 2008 50,000 276.1200 13,806,000
24 October 2008 50,000 272.0200 13,601,000
Accumulated under
the programme 2,838,500 793,731,994
With the transactions stated above, Novo Nordisk owns a total of
24,051,460 treasury shares, corresponding to 3.8% of the share
capital. The total amount of shares in the company is 634,000,000
including treasury shares.
Novo Nordisk is a healthcare company and a world leader in diabetes
care. In addition, Novo Nordisk has a leading position within areas
such as haemostasis management, growth hormone therapy and hormone
replacement therapy. Novo Nordisk manufactures and markets
pharmaceutical products and services that make a significant
difference to patients, the medical profession and society. With
headquarters in Denmark, Novo Nordisk employs approximately 26,550
employees in 80 countries, and markets its products in 179 countries.
Novo Nordisk's B shares are listed on the stock exchanges in
Copenhagen and London. Its ADRs are listed on the New York Stock
Exchange under the symbol 'NVO'. For more information, visit
novonordisk.com.
Further information:
Media: Investors:
Elin K Hansen Mads Veggerby Lausten
Tel: (+45) 4442 3450 Tel: (+45) 4443 7919
ekh@novonordisk.com mlau@novonordisk.com
Hans Rommer
Tel: (+45) 4442 4765
hrmm@novonordisk.com
In North America:
Sean Clements
Tel: (+1) 609 514 8316
secl@novonordisk.com
Company Announcement no 67 / 2008